Microfluidics Market by Product (Devices, Components (Chip, Sensor, Pump, Valve)), Application (IVD (POC, Clinical, Veterinary), Research, Manufacturing, Therapeutics), End User (Hospital, Diagnostic Center, Academic Institutes) - Global Forecast to 2026

世界のマイクロフルイディクス市場予測(~2026):製品別、用途別、エンドユーザー別

◆タイトル:Microfluidics Market by Product (Devices, Components (Chip, Sensor, Pump, Valve)), Application (IVD (POC, Clinical, Veterinary), Research, Manufacturing, Therapeutics), End User (Hospital, Diagnostic Center, Academic Institutes) - Global Forecast to 2026
◆商品コード:AST7541
◆調査・発行会社:MarketsandMarkets
◆発行日:2021年9月28日
◆ページ数:335
◆レポート形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:半導体
◆販売価格オプション(消費税別)
Single User(1名様閲覧)USD4,950 ⇒換算¥564,300見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥758,100見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥929,100見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarketsの日本における正規販売代理店です。

【レポートの概要】

マーケッツアンドマーケッツ社はマイクロフルイディクスの世界市場規模が2021年207億ドルから2026年588億ドルまで、年平均23.2%成長すると予想しています。本調査レポートでは、世界のマイクロフルイディクス市場について調査し、イントロダクション、調査手法、エグゼクティブサマリー、プレミアムインサイト、市場動向、製品別(マイクロ流体デバイス、マイクロ流体コンポーネント)分析、用途別(インビトロ診断、医薬品・生命科学研究・製造、治療)分析、エンドユーザー別(病院・診断センター、学術・研究機関、製薬・バイオテクノロジー企業)分析、地域別分析、競争状況、企業情報などを掲載しています。
・イントロダクション
・調査手法
・エグゼクティブサマリー
・プレミアムインサイト
・市場動向
・マイクロフルイディクスの世界市場規模:製品別(マイクロ流体デバイス、マイクロ流体コンポーネント)
・マイクロフルイディクスの世界市場規模:用途別(インビトロ診断、医薬品・生命科学研究・製造、治療)
・マイクロフルイディクスの世界市場規模:エンドユーザー別(病院・診断センター、学術・研究機関、製薬・バイオテクノロジー企業)
・マイクロフルイディクスの世界市場規模:地域別
・競争状況
・企業情報

“The global microfluidics market is projected to reach USD 58.8 billion by 2026 from USD 20.7 billion in 2021, growing at a CAGR of 23.2% during the forecast period.”
Microfluidic technologies offer quick analysis, reduced reagent consumption, and accurate test results and help in reducing the overall cost of the drug development process. In addition to these factors, the demand for microfluidics technology is increasing owing to the growing demand and adoption of PoC diagnostic devices, such as glucose monitoring and pregnancy test kits.

“Based on product, the microfluidic-based devices segment holds the highest rate during the forecast period.”
Based on product, the microfluidics market is broadly classified into microfluidic-based devices and microfluidic components. In 2020, the microfluidic-based devices segment accounted for the highest rate of the microfluidics market by product. The highest rate of this segment can majorly be attributed to the increasing adoption of technologically advanced microfluidic-based devices in pharmaceutical & life science research, increasing need for miniaturization of laboratory equipment, growing demand for microfluidic-based PoC testing, and the increasing use of microfluidic technology for drug discovery.

“Based on type of product, the microfluidic chips segment holds the highest rate during the forecast period.”
The microfluidic components market, by type, is segmented into microfluidic chips, flow and pressure sensors, flow and pressure controllers, micropumps, microfluidic valves, microneedles, and other microfluidic components. The microfluidic chips segment accounted for the highest rate of the microfluidic components market in 2020. The increasing demand for PoC testing, growing preference for personalized medicine, an increasing number of drug discovery and life science research activities, growing need for high-speed diagnostics, and increasing government funding are factors responsible for the growth of this segment in the microfluidic market.

“Based on application, the in vitro diagnostics segment holds the highest share during the forecast period.”
In this report, the microfluidics market is broadly classified into three major application segments—in vitro diagnostics, pharmaceutical & life science research and manufacturing, and therapeutics. The in vitro diagnostics segment accounted for the largest share of 60.0% of the microfluidics market in 2020. The large share of this segment is mainly attributed to the rising incidence of target diseases and the growing demand for PoC testing. The advantages of microfluidic devices over traditional devices (such as portability, compact size, increased frequency of testing, and accurate & quick analysis) have also driven the adoption of these devices in IVD applications.

“Based on in vitro diagnostics applications, the clinical diagnostic segment holds the highest share during the forecast period.”
The in vitro diagnostics applications segment has been segmented into point-of-care testing, clinical diagnostics, and veterinary diagnostics. The clinical diagnostic testing segment accounted for the largest share of the IVD application segment in 2020, owing to the prevalence of infectious and lifestyle diseases, increased clinical testing due to the COVID-19 pandemic, and the introduction of technologically advanced products.

“APAC is expected to grow at the highest rate in 2020.”
APAC is expected to grow at the highest rate of 25.5% in the forecast year. The rising geriatric population, growing per capita income, increasing investments in the healthcare industry by key market players, rising demand for advanced technologies, and expansion of private-sector hospitals to rural areas in various countries in the Asia Pacific are the major factors driving the growth of the microfluidics market in this region.

Break of primary participants was as mentioned below:
• By Company Type – Tier 1–60%, Tier 2–30%, and Tier 3–10%
• By Designation – C-level–30%, Director-level–50%, Others–20%
• By Region – North America–45%, Europe–15%, Asia Pacific–25%, Latin America- 10%, Middle East and Africa–5%

Key players in the Microfluidics market
The key players in the microfluidics market include Parker Hannifin Corporation (US), SMC Corporation (Japan), IDEX Corporation (US), Fluigent SA (France), Aignep S.P.A. (Italy), Camozzi Automation SPA Societá Unipersonale (Italy), Dolomite microfluidics (UK), Elveflow (France), Cellix Limited (Ireland), Fortive Corporation (US), Danaher Corporation (US), Thermo Fisher Scientific Inc. (US), PerkinElmer, Inc. (US), Agilent Technologies, Inc. (US), Bio-Rad Laboratories, Inc. (US), Becton, Dickinson and Company (US), Illumina Inc. (US), F. Hoffmann-La Roche Ltd. (Switzerland), Fluidigm Corporation (US) and Abbott Laboratories (US).

Research Coverage:
The report analyzes the microfluidics market and aims at estimating the market size and future growth potential of this market based on various segments such as product type, application, end user and region. The report also includes a product portfolio matrix of various microfluidic products available in the market. The report also provides a competitive analysis of the key players in this market, along with their company profiles, product offerings, and key market strategies.

Reasons to Buy the Report
The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them, garner a more significant share of the market. Firms purchasing the report could use one or any combination of the below-mentioned strategies to strengthen their position in the market.

This report provides insights into the following pointers:
• Market Penetration: Comprehensive information on product portfolios offered by the top players in the global microfluidics market. The report analyzes this market by product type, application, end user and region
• Product Enhancement/Innovation: Detailed insights on upcoming trends and product launches in the global microfluidics market
• Market Development: Comprehensive information on the lucrative emerging markets by product type, application, end user and region
• Market Diversification: Exhaustive information about new products or product enhancements, growing geographies, recent developments, and investments in the global microfluidics market
• Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, competitive leadership mapping, and capabilities of leading players in the global microfluidics market.

【レポートの目次】

1 INTRODUCTION 27
1.1 OBJECTIVES OF THE STUDY 27
1.2 MARKET DEFINITION 27
1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY 28
1.3 MARKET SCOPE 29
1.3.1 MARKETS COVERED 29
1.3.2 YEARS CONSIDERED FOR THE STUDY 30
1.4 CURRENCY 30
1.5 STAKEHOLDERS 31
1.6 SUMMARY OF CHANGES 31
2 RESEARCH METHODOLOGY 33
2.1 RESEARCH DATA 33
FIGURE 1 RESEARCH DESIGN 33
2.1.1 SECONDARY DATA 34
2.1.1.1 Key data from secondary sources 35
2.1.2 PRIMARY DATA 35
FIGURE 2 PRIMARY SOURCES 35
2.1.2.1 Key data from primary sources 36
2.1.2.2 Key industry insights 37
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 37
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS 38
2.2 MARKET SIZE ESTIMATION 38
FIGURE 5 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 39
FIGURE 6 REVENUE SHARE ANALYSIS ILLUSTRATION: ABBOTT LABORATORIES 39
FIGURE 7 REVENUE ANALYSIS OF THE TOP FOUR COMPANIES: MICROFLUIDICS-BASED DEVICES MARKET (2020) 40
FIGURE 8 CAGR PROJECTIONS FROM THE ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE MICROFLUIDICS MARKET (2021–2026) 42
FIGURE 9 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 43
FIGURE 10 TOP-DOWN APPROACH 43
2.3 MARKET BREAKDOWN & DATA TRIANGULATION 45
FIGURE 11 MARKET DATA TRIANGULATION METHODOLOGY 45
2.4 MARKET SHARE ANALYSIS 46
2.5 ASSUMPTIONS FOR THE STUDY 46
2.6 RISK ASSESSMENT 47
TABLE 1 RISK ASSESSMENT: MICROFLUIDICS MARKET 47
2.7 LIMITATIONS 47
2.7.1 METHODOLOGY-RELATED LIMITATIONS 47
2.7.2 SCOPE-RELATED LIMITATIONS 47
3 EXECUTIVE SUMMARY 48
FIGURE 12 MICROFLUIDICS MARKET, BY PRODUCT, 2021 VS. 2026 (USD MILLION) 48
FIGURE 13 MICROFLUIDIC COMPONENTS MARKET, BY TYPE,
2021 VS. 2026 (USD MILLION) 49
FIGURE 14 MICROFLUIDICS MARKET, BY APPLICATION, 2021 VS. 2026 (USD MILLION) 50
FIGURE 15 MICROFLUIDICS MARKET FOR IN VITRO DIAGNOSTICS, BY TYPE,
2021 VS. 2026 (USD MILLION) 50
FIGURE 16 MICROFLUIDICS MARKET, BY END USER, 2021 VS. 2026 (USD MILLION) 51
FIGURE 17 GEOGRAPHIC ANALYSIS: GLOBAL MICROFLUIDICS MARKET 52
4 PREMIUM INSIGHTS 53
4.1 GROWTH POTENTIAL OF THE MICROFLUIDICS MARKET 53
FIGURE 18 RISING DEMAND FOR POINT-OF-CARE TESTING IS A KEY FACTOR DRIVING THE GLOBAL MICROFLUIDICS MARKET 53
4.2 ASIA PACIFIC: MICROFLUIDICS MARKET, BY APPLICATION 54
FIGURE 19 CHINA ACCOUNTED FOR THE LARGEST SHARE OF THE ASIA PACIFIC MICROFLUIDICS MARKET IN 2020 54
4.3 MICROFLUIDICS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 55
FIGURE 20 CHINA TO REGISTER THE HIGHEST GROWTH RATE IN THE MICROFLUIDICS MARKET DURING THE FORECAST PERIOD 55
4.4 MICROFLUIDICS MARKET, BY REGION 56
FIGURE 21 NORTH AMERICA TO DOMINATE THE GLOBAL MICROFLUIDICS MARKET DURING THE FORECAST PERIOD 56
4.5 MICROFLUIDICS MARKET: DEVELOPED VS. DEVELOPING MARKETS 56
FIGURE 22 HIGH GROWTH OPPORTUNITIES IN BOTH DEVELOPING AND
DEVELOPED MARKETS DURING THE FORECAST PERIOD 56
5 MARKET OVERVIEW 57
5.1 MARKET DYNAMICS 57
FIGURE 23 MICROFLUIDICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES,
AND CHALLENGES 57
5.1.1 MARKET DRIVERS 58
5.1.1.1 Rising demand for point-of-care testing 58
FIGURE 24 GLOBAL CANCER INCIDENCE, 2015–2040 58
5.1.1.2 Rising technological advancements 59
TABLE 2 SOME NEW PRODUCTS LAUNCHED BY MAJOR PLAYERS IN THE LAST THREE YEARS HAVE BEEN MENTIONED BELOW: 59
5.1.1.3 Increasing focus on data precision and accuracy 60
5.1.1.4 Highly economical 60
5.1.1.5 Rapid testing and improved portability through microfluidic chip miniaturization 61
TABLE 3 MARKET DRIVERS: IMPACT ANALYSIS 61
5.1.2 MARKET RESTRAINTS 62
5.1.2.1 Complex and time-consuming regulatory approval process 62
5.1.2.2 Incorporation of microfluidics into existing workflows 62
TABLE 4 MARKET RESTRAINTS: IMPACT ANALYSIS 63
5.1.3 MARKET OPPORTUNITIES 63
5.1.3.1 Emergence of microfluidic-based 3D cell culture systems 63
5.1.3.2 Asia─ a key growth market 63
5.1.3.3 Expanding applications of drug delivery technologies using microfluidics 64
5.1.3.4 Growing applications of microfluidics in the life sciences & pharmaceutical industries 64
TABLE 5 MARKET OPPORTUNITIES: IMPACT ANALYSIS 65
5.1.4 MARKET CHALLENGES 65
5.1.4.1 Standardization/commercialization of microfluidic devices 65
TABLE 6 MARKET CHALLENGES: IMPACT ANALYSIS 65
5.2 INDUSTRY TRENDS 66
5.2.1 SHIFTING TREND TOWARDS E-HEALTH DIAGNOSTICS WITH THE INTEGRATION OF MICROFLUIDICS-BASED POC DEVICES, EPIDERMAL ELECTRONICS,
AND IOT 66
5.2.2 ADOPTION OF 3D PRINTING IN MICROFLUIDICS 66
5.2.3 SHIFTING TREND TOWARDS THE ADOPTION OF POLYMERS 67
5.2.4 UNIVERSITIES ACTIVELY INVESTING IN MICROFLUIDIC START-UPS 67
TABLE 7 LIST OF UNIVERSITY STARTUPS IN THE MICROFLUIDICS MARKET 67
5.3 VALUE CHAIN ANALYSIS 69
FIGURE 25 MICROFLUIDICS MARKET: VALUE CHAIN ANALYSIS 70
5.3.1 MICROFLUIDIC COMPONENTS PROCUREMENT MODEL OF MAJOR PLAYERS 70
5.4 SUPPLY CHAIN ANALYSIS 71
FIGURE 26 MICROFLUIDICS MARKET: SUPPLY CHAIN ANALYSIS 72
5.5 ECOSYSTEM MARKET MAP 72
FIGURE 27 MICROFLUIDICS MARKET: ECOSYSTEM MARKET MAP 73
5.6 PORTER’S FIVE FORCES ANALYSIS 73
5.6.1 THREAT FROM NEW ENTRANTS 74
5.6.2 THREAT FROM SUBSTITUTES 74
5.6.3 BARGAINING POWER OF SUPPLIERS 74
5.6.4 BARGAINING POWER OF BUYERS 75
5.6.5 INTENSITY OF COMPETITIVE RIVALRY 75
5.7 REGULATORY ANALYSIS 75
5.7.1 NORTH AMERICA 75
5.7.1.1 US 75
TABLE 8 US: CLASSIFICATION OF MICROFLUIDICS TECHNOLOGY ASSOCIATED DIAGNOSTIC DEVICES 76
FIGURE 28 US: REGULATORY PROCESS FOR TESTING DEVICES ASSOCIATED WITH MICROFLUIDICS TECHNOLOGY 76
5.7.1.2 Canada 77
TABLE 9 CANADA: TIME, COST, AND COMPLEXITY OF REGISTRATION 77
FIGURE 29 CANADA: REGULATORY PROCESS FOR MICROFLUIDICS ASSOCIATED IVD DEVICES IN CANADA 77
5.7.2 EUROPE 78
TABLE 10 EUROPE: CLASSIFICATION OF MICROFLUIDICS ASSOCIATED WITH IVD DEVICES 78
FIGURE 30 EUROPE: REGULATORY PROCESS FOR IVD DEVICES 79
5.7.3 ASIA PACIFIC 80
5.7.3.1 Japan 80
TABLE 11 JAPAN: TIME, COST, AND COMPLEXITY OF REGISTRATION 80
5.7.3.2 China 80
TABLE 12 CHINA: TIME, COST, AND COMPLEXITY OF REGISTRATION 81
5.7.3.3 India 81
FIGURE 31 INDIA: REGULATORY PROCESS FOR IVD DEVICES 82
5.8 IMPACT OF COVID-19 ON THE MICROFLUIDIC MARKET 83
FIGURE 32 THERMO FISHER SCIENTIFIC INC.: COVID-19 IMPACT ON
SEGMENTAL ANALYSIS 84
FIGURE 33 ROCHE DIAGNOSTICS.: COVID-19 IMPACT ON SEGMENTAL ANALYSIS 85
FIGURE 34 BIO-RAD LABORATORIES, INC.: COVID-19 IMPACT ON SEGMENTAL ANALYSIS 86
FIGURE 35 ABBOTT LABORATORIES: COVID-19 IMPACT ON SEGMENTAL ANALYSIS 87
5.9 PATENT ANALYSIS 88
5.9.1 PATENT PUBLICATION TRENDS FOR MICROFLUIDICS 88
FIGURE 36 PATENT PUBLICATION TRENDS (2011–SEPTEMBER 2021) 88
5.9.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS 88
FIGURE 37 TOP APPLICANTS AND OWNERS (COMPANIES/INSTITUTIONS) FOR MICROFLUIDICS PATENTS (JANUARY 2011–SEPTEMBER 2021) 89
FIGURE 38 TOP APPLICANT COUNTRIES/REGIONS FOR MICROFLUIDICS PATENTS (JANUARY 2011–SEPTEMBER 2021) 90
5.10 TECHNOLOGY ANALYSIS 90
5.10.1 KEY TECHNOLOGIES 90
5.10.1.1 Biorecognition elements 91
5.10.1.2 Material science 91
5.10.1.3 Microfabrication 92
5.10.1.4 Direct-write 92
5.10.2 COMPLEMENTARY TECHNOLOGIES 92
5.10.2.1 MEMS 93
5.10.2.1.1 Micropumps 93
5.10.2.1.2 Microneedles 93
5.10.2.1.3 Microsensors/Transducers 94
5.10.3 ADJACENT TECHNOLOGIES 94
5.10.3.1 3D Printing 94
5.10.3.2 Lab-on-fiber 95
6 MICROFLUIDICS MARKET, BY PRODUCT 96
6.1 INTRODUCTION 97
TABLE 13 MICROFLUIDICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 97
6.2 MICROFLUIDIC-BASED DEVICES 97
6.2.1 INCREASING ADOPTION OF MICROFLUIDIC DEVICES OWING TO THE VARIOUS ADVANTAGES OFFERED BY MICROFLUIDIC TECHNOLOGY TO DRIVE THE MARKET GROWTH 97
TABLE 14 MICROFLUIDIC-BASED DEVICES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 98
6.3 MICROFLUIDIC COMPONENTS 99
TABLE 15 MICROFLUIDIC COMPONENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 99
TABLE 16 MICROFLUIDIC COMPONENTS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 100
6.3.1 MICROFLUIDIC CHIPS 100
6.3.1.1 Microfluidic chips reduce the analysis time by increasing automation 100
TABLE 17 MICROFLUIDIC CHIPS AVAILABLE IN THE MARKET 101
TABLE 18 MICROFLUIDIC CHIPS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 104
6.3.2 FLOW AND PRESSURE SENSORS 104
6.3.2.1 These devices offer advantages in cytometry and POCT, due to which they are increasingly used in laboratories and research institutes 104
TABLE 19 FLOW AND PRESSURE SENSORS AVAILABLE IN THE MARKET 105
TABLE 20 FLOW AND PRESSURE SENSORS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 106
6.3.3 FLOW AND PRESSURE CONTROLLERS 106
6.3.3.1 Pressure controllers are suitable as references for laboratories owing to their high accuracy and control stability 106
TABLE 21 FLOW AND PRESSURE CONTROLLERS AVAILABLE IN THE MARKET 107
TABLE 22 FLOW AND PRESSURE CONTROLLERS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 108
6.3.4 MICROPUMPS 108
6.3.4.1 The need for precision in fluid control and device miniaturization supports the market growth for micropumps 108
TABLE 23 MICROPUMPS AVAILABLE IN THE MARKET 109
TABLE 24 MICROPUMPS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 110
6.3.5 MICROFLUIDIC VALVES 110
6.3.5.1 Valves are a vital component in microfluidic devices—
a key factor driving the market growth 110
TABLE 25 MICROFLUIDIC VALVES AVAILABLE IN THE MARKET 111
TABLE 26 MICROFLUIDIC VALVES MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 114
6.3.6 MICRONEEDLES 115
6.3.6.1 The small size of microneedles leaves dermal nerves and blood vessels unaffected, thus ensuring a painless procedure 115
TABLE 27 MICRONEEDLES AVAILABLE IN THE MARKET 115
TABLE 28 MICRONEEDLES MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 116
6.3.7 OTHER COMPONENTS 116
TABLE 29 OTHER MICROFLUIDIC COMPONENTS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 117
7 MICROFLUIDICS MARKET, BY APPLICATION 118
7.1 INTRODUCTION 119
TABLE 30 MICROFLUIDICS MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 119
7.2 IN VITRO DIAGNOSTICS 119
TABLE 31 MICROFLUIDICS MARKET FOR IN VITRO DIAGNOSTICS, BY TYPE,
2019–2026 (USD MILLION) 120
TABLE 32 MICROFLUIDICS MARKET FOR IN VITRO DIAGNOSTICS, BY COUNTRY,
2019–2026 (USD MILLION) 121
7.2.1 CLINICAL DIAGNOSTICS 121
7.2.1.1 Increase in viral outbreaks to drive growth in the clinical diagnostics segment 121
TABLE 33 MICROFLUIDICS MARKET FOR CLINICAL DIAGNOSTICS, BY COUNTRY,
2019–2026 (USD MILLION) 122
7.2.2 POINT-OF-CARE TESTING 123
7.2.2.1 Point-of-care testing is the second-largest application segment in the microfluidics market for in vitro diagnostics 123
TABLE 34 MICROFLUIDICS MARKET FOR POINT-OF-CARE TESTING, BY COUNTRY, 2019–2026 (USD MILLION) 124
7.2.3 VETERINARY DIAGNOSTICS 124
7.2.3.1 The growing need for low-cost, rapid, and reliable diagnostic results in veterinary medicine supports the market growth 124
TABLE 35 MICROFLUIDICS MARKET FOR VETERINARY DIAGNOSTICS, BY COUNTRY, 2019–2026 (USD MILLION) 125
7.3 PHARMACEUTICAL & LIFE SCIENCE RESEARCH AND MANUFACTURING 125
FIGURE 39 LAB ANALYTICS ACCOUNTED FOR THE LARGEST SHARE OF THE MARKET
FOR PHARMACEUTICAL & LIFE SCIENCE RESEARCH AND MANUFACTURING IN 202O 126
TABLE 36 MICROFLUIDICS MARKET FOR PHARMACEUTICAL & LIFE SCIENCE RESEARCH AND MANUFACTURING, BY TYPE, 2019–2026 (USD MILLION) 126
TABLE 37 MICROFLUIDICS MARKET FOR PHARMACEUTICAL & LIFE SCIENCE RESEARCH AND MANUFACTURING, BY COUNTRY,
2019–2026 (USD MILLION) 127
7.3.1 LAB ANALYTICS 127
FIGURE 40 PROTEOMIC ANALYSIS TO DOMINATE THE LAB ANALYTICS MARKET
DURING THE FORECAST PERIOD 128
TABLE 38 MICROFLUIDICS MARKET FOR LAB ANALYTICS, BY TYPE,
2019–2026 (USD MILLION) 128
TABLE 39 MICROFLUIDICS MARKET FOR LAB ANALYTICS, BY COUNTRY,
2019–2026 (USD MILLION) 129
7.3.1.1 Proteomic analysis 129
7.3.1.1.1 Increasing demand for rapid proteomic analysis for drug development is propelling the demand for lab-on-a-
chip devices 129
TABLE 40 MICROFLUIDICS MARKET FOR PROTEOMIC ANALYSIS, BY COUNTRY,
2019–2026 (USD MILLION) 130
7.3.1.2 Genomic analysis 131
7.3.1.2.1 Increasing focus on the decoding of genomes to boost the adoption of microfluidics in genomics 131
TABLE 41 MICROFLUIDICS MARKET FOR GENOMIC ANALYSIS, BY COUNTRY,
2019–2026 (USD MILLION) 132
7.3.1.3 Cell-based assays 132
7.3.1.3.1 Increasing focus on microfluidic cell-based assays for rapid drug development supports the market growth 132
TABLE 42 MICROFLUIDICS MARKET FOR CELL-BASED ASSAYS, BY COUNTRY,
2019–2026 (USD MILLION) 133
7.3.1.4 Capillary electrophoresis 133
7.3.1.4.1 Combination of microfluidic capillary electrophoresis with other technologies is expected to drive the overall market growth 133
TABLE 43 MICROFLUIDICS MARKET FOR CAPILLARY ELECTROPHORESIS, BY COUNTRY, 2019–2026 (USD MILLION) 134
7.3.2 MICRODISPENSING 135
7.3.2.1 Less sample and reagent consumption and the ease of operation to drive the adoption of microdispensing systems 135
TABLE 44 MICROFLUIDICS MARKET FOR MICRODISPENSING, BY COUNTRY,
2019–2026 (USD MILLION) 136
7.3.3 MICROREACTION 136
7.3.3.1 The increasing need for optimization in the research and production process using microreaction technology supports market growth 136
TABLE 45 MICROFLUIDICS MARKET FOR MICROREACTION, BY COUNTRY,
2019–2026 (USD MILLION) 137
7.4 THERAPEUTICS 137
FIGURE 41 DRUG DELIVERY APPLICATIONS TO DOMINATE THE THERAPEUTICS MARKET DURING THE FORECAST PERIOD 138
TABLE 46 MICROFLUIDICS MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE,
2019–2026 (USD MILLION) 138
TABLE 47 MICROFLUIDICS MARKET FOR THERAPEUTIC APPLICATIONS, BY COUNTRY, 2019–2026 (USD MILLION) 139
7.4.1 DRUG DELIVERY 139
7.4.1.1 Expanding applications of microfluidics in the development of drug delivery platforms is a key factor driving the market growth 139
TABLE 48 MICROFLUIDICS MARKET FOR DRUG DELIVERY, BY COUNTRY,
2019–2026 (USD MILLION) 140
7.4.2 WEARABLE DEVICES 140
7.4.2.1 Increasing demand for microfluidics-integrated wearable devices for vital monitoring of patients to drive the segment growth 140
TABLE 49 MICROFLUIDICS MARKET FOR WEARABLE DEVICES, BY COUNTRY,
2019–2026 (USD MILLION) 141

8 MICROFLUIDICS MARKET, BY END USER 142
8.1 INTRODUCTION 143
TABLE 50 MICROFLUIDICS MARKET, BY END USER, 2019–2026 (USD MILLION) 143
8.2 HOSPITALS AND DIAGNOSTIC CENTERS 143
8.2.1 HOSPITALS AND DIAGNOSTIC CENTERS ARE THE LARGEST END USERS OF MICROFLUIDIC TECHNOLOGIES 143
TABLE 51 MICROFLUIDICS MARKET FOR HOSPITALS AND DIAGNOSTIC CENTERS,
BY COUNTRY, 2019–2026 (USD MILLION) 144
8.3 ACADEMIC & RESEARCH INSTITUTES 145
8.3.1 THE USE OF MICROFLUIDICS IN R&D IS EXPECTED TO INCREASE WITH GROWING FUNDING INITIATIVES IN LIFE SCIENCES 145
FIGURE 42 LIFE SCIENCE R&D SPENDING (2017–2019) 146
TABLE 52 MICROFLUIDICS MARKET FOR ACADEMIC & RESEARCH INSTITUTES,
BY COUNTRY, 2019–2026 (USD MILLION) 147
8.4 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 147
8.4.1 GROWING FOCUS ON LAUNCHING QUALITY DRUGS TO SUPPORT THE MARKET GROWTH FOR THIS END-USER SEGMENT 147
FIGURE 43 FDA APPROVALS FOR PERSONALIZED MEDICINE (2014–2020) 148
TABLE 53 MICROFLUIDICS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2019–2026 (USD MILLION) 149
9 MICROFLUIDICS MARKET, BY REGION 150
9.1 INTRODUCTION 151
FIGURE 44 MICROFLUIDICS MARKET: GEOGRAPHIC SNAPSHOT (2020) 151
TABLE 54 MICROFLUIDICS MARKET, BY REGION, 2019–2026 (USD MILLION) 152
9.2 NORTH AMERICA 152
FIGURE 45 NORTH AMERICA: MICROFLUIDICS MARKET SNAPSHOT 153
TABLE 55 NORTH AMERICA: MICROFLUIDICS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 154
TABLE 56 NORTH AMERICA: MICROFLUIDICS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 154
TABLE 57 NORTH AMERICA: MICROFLUIDIC COMPONENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 154
TABLE 58 NORTH AMERICA: MICROFLUIDICS MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 155
TABLE 59 NORTH AMERICA: MICROFLUIDICS MARKET FOR IN VITRO DIAGNOSTICS,
BY TYPE, 2019–2026 (USD MILLION) 155
TABLE 60 NORTH AMERICA: MICROFLUIDICS MARKET FOR PHARMACEUTICAL & LIFE SCIENCE RESEARCH AND MANUFACTURING, BY TYPE,
2019–2026 (USD MILLION) 155
TABLE 61 NORTH AMERICA: MICROFLUIDICS MARKET FOR LAB ANALYTICS, BY TYPE, 2019–2026 (USD MILLION) 156
TABLE 62 NORTH AMERICA: MICROFLUIDICS MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2019–2026 (USD MILLION) 156
TABLE 63 NORTH AMERICA: MICROFLUIDICS MARKET, BY END USER,
2019–2026 (USD MILLION) 156
9.2.1 US 157
9.2.1.1 The US dominates the microfluidics market in North America 157
TABLE 64 US: KEY MACROINDICATORS 157
TABLE 65 US: MICROFLUIDICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 158
TABLE 66 US: MICROFLUIDIC COMPONENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 158
TABLE 67 US: MICROFLUIDICS MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 158
TABLE 68 US: MICROFLUIDICS MARKET FOR IN VITRO DIAGNOSTICS, BY TYPE,
2019–2026 (USD MILLION) 159
TABLE 69 US: MICROFLUIDICS MARKET FOR PHARMACEUTICAL & LIFE SCIENCE RESEARCH AND MANUFACTURING, BY TYPE, 2019–2026 (USD MILLION) 159
TABLE 70 US: MICROFLUIDICS MARKET FOR LAB ANALYTICS, BY TYPE,
2019–2026 (USD MILLION) 159
TABLE 71 US: MICROFLUIDICS MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2019–2026 (USD MILLION) 160
TABLE 72 US: MICROFLUIDICS MARKET, BY END USER, 2019–2026 (USD MILLION) 160
9.2.2 CANADA 160
9.2.2.1 Strong infrastructure and the availability of funding for biomedical research to support the market growth 160
TABLE 73 CANADA: KEY MACROINDICATORS 161
TABLE 74 CANADA: MICROFLUIDICS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 161
TABLE 75 CANADA: MICROFLUIDIC COMPONENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 162
TABLE 76 CANADA: MICROFLUIDICS MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 162
TABLE 77 CANADA: MICROFLUIDICS MARKET FOR IN VITRO DIAGNOSTICS, BY TYPE, 2019–2026 (USD MILLION) 162
TABLE 78 CANADA: MICROFLUIDICS MARKET FOR PHARMACEUTICAL & LIFE SCIENCE RESEARCH AND MANUFACTURING, BY TYPE, 2019–2026 (USD MILLION) 163
TABLE 79 CANADA: MICROFLUIDICS MARKET FOR LAB ANALYTICS, BY TYPE,
2019–2026 (USD MILLION) 163
TABLE 80 CANADA: MICROFLUIDICS MARKET FOR THERAPEUTIC APPLICATIONS,
BY TYPE, 2019–2026 (USD MILLION) 163
TABLE 81 CANADA: MICROFLUIDICS MARKET, BY END USER,
2019–2026 (USD MILLION) 164
9.3 EUROPE 164
TABLE 82 EUROPE: MICROFLUIDICS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 165
TABLE 83 EUROPE: MICROFLUIDICS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 165
TABLE 84 EUROPE: MICROFLUIDIC COMPONENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 166
TABLE 85 EUROPE: MICROFLUIDICS MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 166
TABLE 86 EUROPE: MICROFLUIDICS MARKET FOR IN VITRO DIAGNOSTICS, BY TYPE, 2019–2026 (USD MILLION) 166
TABLE 87 EUROPE: MICROFLUIDICS MARKET FOR PHARMACEUTICAL & LIFE SCIENCE RESEARCH AND MANUFACTURING, BY TYPE, 2019–2026 (USD MILLION) 167
TABLE 88 EUROPE: MICROFLUIDICS MARKET FOR LAB ANALYTICS, BY TYPE,
2019–2026 (USD MILLION) 167
TABLE 89 EUROPE: MICROFLUIDICS MARKET FOR THERAPEUTIC APPLICATIONS,
BY TYPE, 2019–2026 (USD MILLION) 167
TABLE 90 EUROPE: MICROFLUIDICS MARKET, BY END USER,
2019–2026 (USD MILLION) 168
9.3.1 GERMANY 168
9.3.1.1 Germany holds the largest share in the European market 168
TABLE 91 GERMANY: KEY MACROINDICATORS 169
TABLE 92 GERMANY: MICROFLUIDICS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 169
TABLE 93 GERMANY: MICROFLUIDIC COMPONENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 170
TABLE 94 GERMANY: MICROFLUIDICS MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 170
TABLE 95 GERMANY: MICROFLUIDICS MARKET FOR IN VITRO DIAGNOSTICS, BY TYPE, 2019–2026 (USD MILLION) 170
TABLE 96 GERMANY: MICROFLUIDICS MARKET FOR PHARMACEUTICAL & LIFE SCIENCE RESEARCH AND MANUFACTURING, BY TYPE, 2019–2026 (USD MILLION) 171
TABLE 97 GERMANY: MICROFLUIDICS MARKET FOR LAB ANALYTICS, BY TYPE,
2019–2026 (USD MILLION) 171
TABLE 98 GERMANY: MICROFLUIDICS MARKET FOR THERAPEUTIC APPLICATIONS,
BY TYPE, 2019–2026 (USD MILLION) 171
TABLE 99 GERMANY: MICROFLUIDICS MARKET, BY END USER,
2019–2026 (USD MILLION) 172
9.3.2 FRANCE 172
9.3.2.1 Genomics and proteomics research is strongly supported by the government of France 172
TABLE 100 FRANCE: KEY MACROINDICATORS 173
TABLE 101 FRANCE: MICROFLUIDICS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 173
TABLE 102 FRANCE: MICROFLUIDIC COMPONENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 173
TABLE 103 FRANCE: MICROFLUIDICS MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 174
TABLE 104 FRANCE: MICROFLUIDICS MARKET FOR IN VITRO DIAGNOSTICS, BY TYPE, 2019–2026 (USD MILLION) 174
TABLE 105 FRANCE: MICROFLUIDICS MARKET FOR PHARMACEUTICAL & LIFE SCIENCE RESEARCH AND MANUFACTURING, BY TYPE, 2019–2026 (USD MILLION) 174
TABLE 106 FRANCE: MICROFLUIDICS MARKET FOR LAB ANALYTICS, BY TYPE,
2019–2026 (USD MILLION) 175
TABLE 107 FRANCE: MICROFLUIDICS MARKET FOR THERAPEUTIC APPLICATIONS,
BY TYPE, 2019–2026 (USD MILLION) 175
TABLE 108 FRANCE: MICROFLUIDICS MARKET, BY END USER,
2019–2026 (USD MILLION) 175

9.3.3 UK 176
9.3.3.1 Increasing incidence of infectious diseases such as COVID-19 drives the growth of PoC testing and microfluidics 176
TABLE 109 UK: KEY MACROINDICATORS 176
TABLE 110 UK: MICROFLUIDICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 176
TABLE 111 UK: MICROFLUIDIC COMPONENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 177
TABLE 112 UK: MICROFLUIDICS MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 177
TABLE 113 UK: MICROFLUIDICS MARKET FOR IN VITRO DIAGNOSTICS, BY TYPE,
2019–2026 (USD MILLION) 177
TABLE 114 UK: MICROFLUIDICS MARKET FOR PHARMACEUTICAL & LIFE SCIENCE RESEARCH AND MANUFACTURING, BY TYPE, 2019–2026 (USD MILLION) 178
TABLE 115 UK: MICROFLUIDICS MARKET FOR LAB ANALYTICS, BY TYPE,
2019–2026 (USD MILLION) 178
TABLE 116 UK: MICROFLUIDICS MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2019–2026 (USD MILLION) 178
TABLE 117 UK: MICROFLUIDICS MARKET, BY END USER, 2019–2026 (USD MILLION) 179
9.3.4 ITALY 179
9.3.4.1 Increasing demand for PoC testing aids market growth 179
TABLE 118 ITALY: KEY MACROINDICATORS 180
TABLE 119 ITALY: MICROFLUIDICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 180
TABLE 120 ITALY: MICROFLUIDIC COMPONENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 180
TABLE 121 ITALY: MICROFLUIDICS MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 181
TABLE 122 ITALY: MICROFLUIDICS MARKET FOR IN VITRO DIAGNOSTICS, BY TYPE, 2019–2026 (USD MILLION) 181
TABLE 123 ITALY: MICROFLUIDICS MARKET FOR PHARMACEUTICAL & LIFE SCIENCE RESEARCH AND MANUFACTURING, BY TYPE, 2019–2026 (USD MILLION) 181
TABLE 124 ITALY: MICROFLUIDICS MARKET FOR LAB ANALYTICS, BY TYPE,
2019–2026 (USD MILLION) 182
TABLE 125 ITALY: MICROFLUIDICS MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2019–2026 (USD MILLION) 182
TABLE 126 ITALY: MICROFLUIDICS MARKET, BY END USER, 2019–2026 (USD MILLION) 182
9.3.5 SPAIN 183
9.3.5.1 Increasing incidence of infectious and chronic diseases drives the growth of the market 183
TABLE 127 SPAIN: KEY MACROINDICATORS 184
TABLE 128 SPAIN: MICROFLUIDICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 184
TABLE 129 SPAIN: MICROFLUIDIC COMPONENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 184
TABLE 130 SPAIN: MICROFLUIDICS MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 185
TABLE 131 SPAIN: MICROFLUIDICS MARKET FOR IN VITRO DIAGNOSTICS, BY TYPE, 2019–2026 (USD MILLION) 185
TABLE 132 SPAIN: MICROFLUIDICS MARKET FOR PHARMACEUTICAL & LIFE SCIENCE RESEARCH AND MANUFACTURING, BY TYPE, 2019–2026 (USD MILLION) 185
TABLE 133 SPAIN: MICROFLUIDICS MARKET FOR LAB ANALYTICS, BY TYPE,
2019–2026 (USD MILLION) 186
TABLE 134 SPAIN: MICROFLUIDICS MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2019–2026 (USD MILLION) 186
TABLE 135 SPAIN: MICROFLUIDICS MARKET, BY END USER, 2019–2026 (USD MILLION) 186
9.3.6 BENELUX 187
9.3.6.1 Increasing healthcare expenditure in Benelux to drive the growth of the microfluidics market 187
TABLE 136 BENELUX: MICROFLUIDICS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 187
TABLE 137 BENELUX: MICROFLUIDIC COMPONENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 188
TABLE 138 BENELUX: MICROFLUIDICS MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 188
TABLE 139 BENELUX: MICROFLUIDICS MARKET FOR IN VITRO DIAGNOSTICS, BY TYPE, 2019–2026 (USD MILLION) 188
TABLE 140 BENELUX: MICROFLUIDICS MARKET FOR PHARMACEUTICAL & LIFE SCIENCE RESEARCH AND MANUFACTURING, BY TYPE, 2019–2026 (USD MILLION) 189
TABLE 141 BENELUX: MICROFLUIDICS MARKET FOR LAB ANALYTICS, BY TYPE,
2019–2026 (USD MILLION) 189
TABLE 142 BENELUX MICROFLUIDICS MARKET FOR THERAPEUTIC APPLICATIONS,
BY TYPE, 2019–2026 (USD MILLION) 189
TABLE 143 BENELUX: MICROFLUIDICS MARKET, BY END USER,
2019–2026 (USD MILLION) 190
9.3.7 REST OF EUROPE 190
TABLE 144 ROE: MICROFLUIDICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 191
TABLE 145 ROE: MICROFLUIDIC COMPONENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 191
TABLE 146 ROE: MICROFLUIDICS MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 191
TABLE 147 ROE: MICROFLUIDICS MARKET FOR IN VITRO DIAGNOSTICS, BY TYPE,
2019–2026 (USD MILLION) 192
TABLE 148 ROE: MICROFLUIDICS MARKET FOR PHARMACEUTICAL & LIFE SCIENCE RESEARCH AND MANUFACTURING, BY TYPE, 2019–2026 (USD MILLION) 192
TABLE 149 ROE: MICROFLUIDICS MARKET FOR LAB ANALYTICS, BY TYPE,
2019–2026 (USD MILLION) 192
TABLE 150 ROE: MICROFLUIDICS MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2019–2026 (USD MILLION) 193
TABLE 151 ROE: MICROFLUIDICS MARKET, BY END USER, 2019–2026 (USD MILLION) 193
9.4 ASIA PACIFIC 193
FIGURE 46 ASIA PACIFIC: MICROFLUIDICS MARKET SNAPSHOT 195
TABLE 152 ASIA PACIFIC: MICROFLUIDICS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 196
TABLE 153 ASIA PACIFIC: MICROFLUIDICS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 196
TABLE 154 ASIA PACIFIC: MICROFLUIDIC COMPONENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 197
TABLE 155 ASIA PACIFIC: MICROFLUIDICS MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 197
TABLE 156 ASIA PACIFIC: MICROFLUIDICS MARKET FOR IN VITRO DIAGNOSTICS,
BY TYPE, 2019–2026 (USD MILLION) 197
TABLE 157 ASIA PACIFIC: MICROFLUIDICS MARKET FOR PHARMACEUTICAL & LIFE SCIENCE RESEARCH AND MANUFACTURING, BY TYPE,
2019–2026 (USD MILLION) 198
TABLE 158 ASIA PACIFIC: MICROFLUIDICS MARKET FOR LAB ANALYTICS, BY TYPE, 2019–2026 (USD MILLION) 198
TABLE 159 ASIA PACIFIC: MICROFLUIDICS MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2019–2026 (USD MILLION) 198
TABLE 160 ASIA PACIFIC: MICROFLUIDICS MARKET, BY END USER,
2019–2026 (USD MILLION) 199
9.4.1 CHINA 199
9.4.1.1 China holds a major share in the Asia Pacific microfluidics market 199
TABLE 161 CHINA: KEY MACROINDICATORS 200
TABLE 162 CHINA: MICROFLUIDICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 200
TABLE 163 CHINA: MICROFLUIDIC COMPONENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 201
TABLE 164 CHINA: MICROFLUIDICS MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 201
TABLE 165 CHINA: MICROFLUIDICS MARKET FOR IN VITRO DIAGNOSTICS, BY TYPE, 2019–2026 (USD MILLION) 201
TABLE 166 CHINA: MICROFLUIDICS MARKET FOR PHARMACEUTICAL & LIFE SCIENCE RESEARCH AND MANUFACTURING, BY TYPE, 2019–2026 (USD MILLION) 202
TABLE 167 CHINA: MICROFLUIDICS MARKET FOR LAB ANALYTICS, BY TYPE,
2019–2026 (USD MILLION) 202
TABLE 168 CHINA: MICROFLUIDICS MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2019–2026 (USD MILLION) 202
TABLE 169 CHINA: MICROFLUIDICS MARKET, BY END USER, 2019–2026 (USD MILLION) 203
9.4.2 JAPAN 203
9.4.2.1 Adoption of technologically advanced laboratory analytical instruments in research to drive market growth in Japan 203
TABLE 170 JAPAN: KEY MACROINDICATORS 204
TABLE 171 JAPAN: MICROFLUIDICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 204
TABLE 172 JAPAN: MICROFLUIDIC COMPONENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 205
TABLE 173 JAPAN: MICROFLUIDICS MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 205
TABLE 174 JAPAN: MICROFLUIDICS MARKET FOR IN VITRO DIAGNOSTICS, BY TYPE, 2019–2026 (USD MILLION) 205
TABLE 175 JAPAN: MICROFLUIDICS MARKET FOR PHARMACEUTICAL & LIFE SCIENCE RESEARCH AND MANUFACTURING, BY TYPE, 2019–2026 (USD MILLION) 206
TABLE 176 JAPAN: MICROFLUIDICS MARKET FOR LAB ANALYTICS, BY TYPE,
2019–2026 (USD MILLION) 206
TABLE 177 JAPAN: MICROFLUIDICS MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2019–2026 (USD MILLION) 206
TABLE 178 JAPAN: MICROFLUIDICS MARKET, BY END USER, 2019–2026 (USD MILLION) 207
9.4.3 INDIA 207
9.4.3.1 Increasing pharma R&D and government funding in the biotechnology sector is a major factor driving the market growth
in India 207
TABLE 179 INDIA: KEY MACROINDICATORS 208
TABLE 180 INDIA: MICROFLUIDICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 208
TABLE 181 INDIA: MICROFLUIDIC COMPONENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 209
TABLE 182 INDIA: MICROFLUIDICS MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 209
TABLE 183 INDIA: MICROFLUIDICS MARKET FOR IN VITRO DIAGNOSTICS, BY TYPE, 2019–2026 (USD MILLION) 209
TABLE 184 INDIA: MICROFLUIDICS MARKET FOR PHARMACEUTICAL & LIFE SCIENCE RESEARCH AND MANUFACTURING, BY TYPE, 2019–2026 (USD MILLION) 210
TABLE 185 INDIA: MICROFLUIDICS MARKET FOR LAB ANALYTICS, BY TYPE,
2019–2026 (USD MILLION) 210
TABLE 186 INDIA: MICROFLUIDICS MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2019–2026 (USD MILLION) 210
TABLE 187 INDIA: MICROFLUIDICS MARKET, BY END USER, 2019–2026 (USD MILLION) 211
9.4.4 SOUTHEAST ASIA (SEA) 211
9.4.4.1 Growth in the market can be attributed to developing healthcare infrastructure and growing government support 211
FIGURE 47 HEALTHCARE EXPENDITURE (% GDP) IN SOUTHEAST ASIA (2018) 212
FIGURE 48 GERIATRIC POPULATION IN 2019 (% OF TOTAL POPULATION) 212
TABLE 188 SEA: MICROFLUIDICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 212
TABLE 189 SEA: MICROFLUIDIC COMPONENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 213
TABLE 190 SEA: MICROFLUIDICS MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 213
TABLE 191 SEA: MICROFLUIDICS MARKET FOR IN VITRO DIAGNOSTICS, BY TYPE,
2019–2026 (USD MILLION) 214
TABLE 192 SEA: MICROFLUIDICS MARKET FOR PHARMACEUTICAL & LIFE SCIENCE RESEARCH AND MANUFACTURING, BY TYPE, 2019–2026 (USD MILLION) 214
TABLE 193 SEA: MICROFLUIDICS MARKET FOR LAB ANALYTICS, BY TYPE,
2019–2026 (USD MILLION) 214
TABLE 194 SEA: MICROFLUIDICS MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2019–2026 (USD MILLION) 215
TABLE 195 SEA: MICROFLUIDICS MARKET, BY END USER, 2019–2026 (USD MILLION) 215
9.4.5 REST OF ASIA PACIFIC 215
TABLE 196 ROAPAC: MICROFLUIDICS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 215
TABLE 197 ROAPAC: MICROFLUIDIC COMPONENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 216
TABLE 198 ROAPAC: MICROFLUIDICS MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 216
TABLE 199 ROAPAC: MICROFLUIDICS MARKET FOR IN VITRO DIAGNOSTICS, BY TYPE, 2019–2026 (USD MILLION) 216
TABLE 200 ROAPAC: MICROFLUIDICS MARKET FOR PHARMACEUTICAL & LIFE SCIENCE RESEARCH AND MANUFACTURING, BY TYPE, 2019–2026 (USD MILLION) 217
TABLE 201 ROAPAC: MICROFLUIDICS MARKET FOR LAB ANALYTICS, BY TYPE,
2019–2026 (USD MILLION) 217
TABLE 202 ROAPAC: MICROFLUIDICS MARKET FOR THERAPEUTIC APPLICATIONS,
BY TYPE, 2019–2026 (USD MILLION) 217
TABLE 203 ROAPAC: MICROFLUIDICS MARKET, BY END USER,
2019–2026 (USD MILLION) 218

9.5 LATIN AMERICA 218
TABLE 204 LATIN AMERICA: MICROFLUIDICS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 218
TABLE 205 LATIN AMERICA: MICROFLUIDICS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 219
TABLE 206 LATIN AMERICA: MICROFLUIDIC COMPONENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 219
TABLE 207 LATIN AMERICA: MICROFLUIDICS MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 219
TABLE 208 LATIN AMERICA: MICROFLUIDICS MARKET FOR IN VITRO DIAGNOSTICS,
BY TYPE, 2019–2026 (USD MILLION) 220
TABLE 209 LATIN AMERICA: MICROFLUIDICS MARKET FOR PHARMACEUTICAL & LIFE SCIENCE RESEARCH AND MANUFACTURING, BY TYPE,
2019–2026 (USD MILLION) 220
TABLE 210 LATIN AMERICA: MICROFLUIDICS MARKET FOR LAB ANALYTICS, BY TYPE, 2019–2026 (USD MILLION) 220
TABLE 211 LATIN AMERICA: MICROFLUIDICS MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2019–2026 (USD MILLION) 221
TABLE 212 LATIN AMERICA: MICROFLUIDICS MARKET, BY END USER,
2019–2026 (USD MILLION) 221
9.5.1 BRAZIL 221
9.5.1.1 Pharmaceutical & biologics QC to drive the market growth in Brazil 221
TABLE 213 BRAZIL: KEY MACROINDICATORS 222
TABLE 214 BRAZIL: MICROFLUIDICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 222
TABLE 215 BRAZIL: MICROFLUIDIC COMPONENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 222
TABLE 216 BRAZIL: MICROFLUIDICS MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 223
TABLE 217 BRAZIL: MICROFLUIDICS MARKET FOR IN VITRO DIAGNOSTICS, BY TYPE, 2019–2026 (USD MILLION) 223
TABLE 218 BRAZIL: MICROFLUIDICS MARKET FOR PHARMACEUTICAL & LIFE SCIENCE RESEARCH AND MANUFACTURING, BY TYPE, 2019–2026 (USD MILLION) 223
TABLE 219 BRAZIL: MICROFLUIDICS MARKET FOR LAB ANALYTICS, BY TYPE,
2019–2026 (USD MILLION) 224
TABLE 220 BRAZIL: MICROFLUIDICS MARKET FOR THERAPEUTIC APPLICATIONS,
BY TYPE, 2019–2026 (USD MILLION) 224
TABLE 221 BRAZIL: MICROFLUIDICS MARKET, BY END USER,
2019–2026 (USD MILLION) 224

9.5.2 MEXICO 225
9.5.2.1 The rising prevalence of chronic diseases drives the growth of the microfluidics market in Mexico 225
TABLE 222 MEXICO: KEY MACROINDICATORS 225
TABLE 223 MEXICO: MICROFLUIDICS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 225
TABLE 224 MEXICO: MICROFLUIDIC COMPONENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 226
TABLE 225 MEXICO: MICROFLUIDICS MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 226
TABLE 226 MEXICO: MICROFLUIDICS MARKET FOR IN VITRO DIAGNOSTICS, BY TYPE, 2019–2026 (USD MILLION) 226
TABLE 227 MEXICO: MICROFLUIDICS MARKET FOR PHARMACEUTICAL & LIFE SCIENCE RESEARCH AND MANUFACTURING, BY TYPE, 2019–2026 (USD MILLION) 227
TABLE 228 MEXICO: MICROFLUIDICS MARKET FOR LAB ANALYTICS, BY TYPE,
2019–2026 (USD MILLION) 227
TABLE 229 MEXICO: MICROFLUIDICS MARKET FOR THERAPEUTIC APPLICATIONS,
BY TYPE, 2019–2026 (USD MILLION) 227
TABLE 230 MEXICO: MICROFLUIDICS MARKET, BY END USER,
2019–2026 (USD MILLION) 228
9.5.3 REST OF LATIN AMERICA (ROLATAM) 228
TABLE 231 ROLATAM: MICROFLUIDICS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 228
TABLE 232 ROLA: MICROFLUIDIC COMPONENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 229
TABLE 233 ROLA: MICROFLUIDICS MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 229
TABLE 234 ROLA: MICROFLUIDICS MARKET FOR IN VITRO DIAGNOSTICS, BY TYPE, 2019–2026 (USD MILLION) 229
TABLE 235 ROLA: MICROFLUIDICS MARKET FOR PHARMACEUTICAL & LIFE SCIENCE RESEARCH AND MANUFACTURING, BY TYPE, 2019–2026 (USD MILLION) 230
TABLE 236 ROLA: MICROFLUIDICS MARKET FOR LAB ANALYTICS, BY TYPE,
2019–2026 (USD MILLION) 230
TABLE 237 ROLA: MICROFLUIDICS MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2019–2026 (USD MILLION) 230
TABLE 238 ROLA: MICROFLUIDICS MARKET, BY END USER, 2019–2026 (USD MILLION) 231
9.6 MIDDLE EAST & AFRICA 231
9.6.1 THE MEA IS CONSIDERED A PROMISING REGION, ESPECIALLY FOR MICROFLUIDIC DRUG DELIVERY FIRMS 231
TABLE 239 MEA: MICROFLUIDICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 232
TABLE 240 MEA: MICROFLUIDIC COMPONENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 232
TABLE 241 MEA: MICROFLUIDICS MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 232
TABLE 242 MEA: MICROFLUIDICS MARKET FOR IN VITRO DIAGNOSTICS, BY TYPE,
2019–2026 (USD MILLION) 233
TABLE 243 MEA: MICROFLUIDICS MARKET FOR PHARMACEUTICAL & LIFE SCIENCE RESEARCH AND MANUFACTURING, BY TYPE, 2019–2026 (USD MILLION) 233
TABLE 244 MEA: MICROFLUIDICS MARKET FOR LAB ANALYTICS, BY TYPE,
2019–2026 (USD MILLION) 233
TABLE 245 MEA: MICROFLUIDICS MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2019–2026 (USD MILLION) 234
TABLE 246 MEA: MICROFLUIDICS MARKET, BY END USER, 2019–2026 (USD MILLION) 234
10 COMPETITIVE LANDSCAPE 235
10.1 OVERVIEW 235
10.2 KEY PLAYER STRATEGIES 235
10.3 REVENUE SHARE ANALYSIS OF THE TOP MARKET PLAYERS 236
FIGURE 49 REVENUE ANALYSIS OF THE TOP PLAYERS IN THE MICROFLUIDICS-BASED DEVICE MARKET 236
10.4 MARKET SHARE ANALYSIS 236
FIGURE 50 MICROFLUIDICS-BASED DEVICES MARKET SHARE, BY KEY PLAYER, 2020 237
10.5 MARKET RANKING 238
TABLE 247 MICROFLUIDIC VALVES MARKET RANKING, BY KEY PLAYER, 2020 238
TABLE 248 MICROPUMPS MARKET RANKING, BY KEY PLAYER, 2020 238
10.6 COMPANY EVALUATION QUADRANT 239
10.6.1 STARS 239
10.6.2 EMERGING LEADERS 239
10.6.3 PERVASIVE PLAYERS 239
10.6.4 PARTICIPANTS 239
FIGURE 51 MICROFLUIDICSMARKET: COMPANY EVALUATION QUADRANT (2020) 240
10.7 COMPANY EVALUATION QUADRANT FOR START-UPS 241
10.7.1 PROGRESSIVE COMPANIES 241
10.7.2 DYNAMIC COMPANIES 241
10.7.3 STARTING BLOCKS 241
10.7.4 RESPONSIVE COMPANIES 241
FIGURE 52 MICROFLUIDICS MARKET: COMPANY EVALUATION QUADRANT FOR
START-UPS (2020) 242
10.8 COMPANY PRODUCT FOOTPRINT 243
TABLE 249 PRODUCT PORTFOLIO ANALYSIS: MICROFLUIDICS MARKET 243
TABLE 250 APPLICATION PORTFOLIO ANALYSIS: MICROFLUIDICS MARKET 245
TABLE 251 END-USER PORTFOLIO ANALYSIS: MICROFLUIDICS MARKET 247
10.9 GEOGRAPHIC FOOTPRINT OF THE MAJOR PLAYERS IN THE MICROFLUIDICS MARKET 249
TABLE 252 GEOGRAPHIC REVENUE MIX: MICROFLUIDICS MARKET (2020) 249
10.10 COMPETITIVE SCENARIO 251
10.10.1 PRODUCT LAUNCHES 251
TABLE 253 PRODUCT LAUNCHES 251
10.10.2 DEALS 252
10.10.3 OTHER DEVELOPMENTS 253
TABLE 255 OTHER DEVELOPMENTS 253

11 COMPANY PROFILES 254
11.1 KEY PLAYERS 254
(Business overview, Products offered, Recent Developments, MNM view)*
11.1.1 PARKER-HANNIFIN CORPORATION 254
TABLE 256 PARKER-HANNIFIN CORPORATION: BUSINESS OVERVIEW 254
FIGURE 53 PARKER-HANNIFIN CORPORATION: COMPANY SNAPSHOT (2020) 255
11.1.2 SMC CORPORATION 259
TABLE 257 SMC CORPORATION: BUSINESS OVERVIEW 259
FIGURE 54 SMC CORPORATION: COMPANY SNAPSHOT (2020) 259
11.1.3 IDEX CORPORATION 264
TABLE 258 IDEX CORPORATION: BUSINESS OVERVIEW 264
FIGURE 55 IDEX CORPORATION: COMPANY SNAPSHOT (2020) 265
11.1.4 FORTIVE CORPORATION 267
TABLE 259 FORTIVE CORPORATION: BUSINESS OVERVIEW 267
FIGURE 56 FORTIVE CORPORATION: COMPANY SNAPSHOT (2020) 268
11.1.5 DANAHER CORPORATION 272
TABLE 260 DANAHER CORPORATION: BUSINESS OVERVIEW 272
FIGURE 57 DANAHER CORPORATION: COMPANY SNAPSHOT (2020) 273
11.1.6 THERMO FISHER SCIENTIFIC INC. 276
TABLE 261 THERMO FISHER SCIENTIFIC INC.: BUSINESS OVERVIEW 276
FIGURE 58 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2020) 277
11.1.7 PERKINELMER, INC. 280
TABLE 262 PERKINELMER, INC.: BUSINESS OVERVIEW 280
FIGURE 59 PERKINELMER, INC.: COMPANY SNAPSHOT (2020) 281
11.1.8 AGILENT TECHNOLOGIES, INC. 283
TABLE 263 AGILENT TECHNOLOGIES, INC.: BUSINESS OVERVIEW 283
FIGURE 60 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2020) 284
11.1.9 BIO-RAD LABORATORIES, INC. 286
TABLE 264 BIO-RAD LABORATORIES, INC.: BUSINESS OVERVIEW 286
FIGURE 61 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2020) 287
11.1.10 BECTON, DICKINSON AND COMPANY 290
TABLE 265 BECTON, DICKINSON AND COMPANY: BUSINESS OVERVIEW 290
FIGURE 62 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2020) 291
11.1.11 ILLUMINA INC. 293
TABLE 266 ILLUMINA INC.: BUSINESS OVERVIEW 293
FIGURE 63 ILLUMINA INC.: COMPANY SNAPSHOT (2020) 294
11.1.12 FLUIGENT SA 297
TABLE 267 FLUIGENT SA: BUSINESS OVERVIEW 297
11.1.13 AIGNEP S.P.A. 300
TABLE 268 AIGNEP S.P.A.: BUSINESS OVERVIEW 300
11.1.14 F. HOFFMANN-LA ROCHE LTD. 301
TABLE 269 F. HOFFMANN-LA ROCHE LTD.: BUSINESS OVERVIEW 301
FIGURE 64 F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT (2020) 302
11.1.15 FLUIDIGM CORPORATION 304
TABLE 270 FLUIDIGM CORPORATION: BUSINESS OVERVIEW 304
FIGURE 65 FLUIDIGM CORPORATION: COMPANY SNAPSHOT (2020) 305
11.1.16 ABBOTT LABORATORIES 308
TABLE 271 ABBOTT LABORATORIES: BUSINESS OVERVIEW 308
FIGURE 66 ABBOTT LABORATORIES: COMPANY SNAPSHOT (2020) 309
11.1.17 CAMOZZI AUTOMATION SPA SOCIETÁ UNIPERSONALE 311
TABLE 272 CAMOZZI AUTOMATION SPA SOCIETA UNIPERSONALE : BUSINESS OVERVIEW 311
11.1.18 DOLOMITE MICROFLUIDICS 313
TABLE 273 DOLOMITE MICROFLUIDICS: BUSINESS OVERVIEW 313
11.1.19 ELVEFLOW 319
TABLE 274 ELVEFLOW: BUSINESS OVERVIEW 319
11.1.20 CELLIX LTD. 321
TABLE 275 CELLIX LTD. : BUSINESS OVERVIEW 321
*Details on Business overview, Products offered, Recent Developments, MNM view might not be captured in case of unlisted companies.
11.2 OTHER PLAYERS 323
11.2.1 NANOSTRING 323
TABLE 276 NANOSTRING : COMPANY OVERVIEW 323
11.2.2 NORTIS INC. 324
TABLE 277 NORTIS INC. : COMPANY OVERVIEW 324
11.2.3 INNOVATIVE BIOCHIPS, LLC 325
TABLE 278 INNOVATIVE BIOCHIPS, LLC. : COMPANY OVERVIEW 325
11.2.4 FLUIDIC ANALYTICS 326
TABLE 279 FLUIDICS ANALYTICS : COMPANY OVERVIEW 326
11.2.5 EPIGEM INC. 326
TABLE 280 EPIGEM INC. : COMPANY OVERVIEW 326
12 APPENDIX 327
12.1 DISCUSSION GUIDE 327
12.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 332
12.3 AVAILABLE CUSTOMIZATIONS 334
12.4 RELATED REPORTS 334
12.5 AUTHOR DETAILS 335

★調査レポート[世界のマイクロフルイディクス市場予測(~2026):製品別、用途別、エンドユーザー別] ( Microfluidics Market by Product (Devices, Components (Chip, Sensor, Pump, Valve)), Application (IVD (POC, Clinical, Veterinary), Research, Manufacturing, Therapeutics), End User (Hospital, Diagnostic Center, Academic Institutes) - Global Forecast to 2026 / AST7541) 販売に関する免責事項
[世界のマイクロフルイディクス市場予測(~2026):製品別、用途別、エンドユーザー別] ( Microfluidics Market by Product (Devices, Components (Chip, Sensor, Pump, Valve)), Application (IVD (POC, Clinical, Veterinary), Research, Manufacturing, Therapeutics), End User (Hospital, Diagnostic Center, Academic Institutes) - Global Forecast to 2026 / AST7541) についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆